首页|急性缺血性脑卒中静脉溶栓后出血转化危险因素及治疗研究进展

急性缺血性脑卒中静脉溶栓后出血转化危险因素及治疗研究进展

扫码查看
静脉溶栓是临床治疗急性缺血性脑卒中(AIS)的常用方法,可及时恢复脑组织血流灌注,挽救濒临死亡的神经功能,提高血管再通率,降低死亡率.但AIS患者在静脉溶栓后容易出现出血转化(HT),HT作为AIS患者静脉溶栓后较为严重的一种并发症,会抵消或降低静脉溶栓治疗给患者带来的获益,对患者生命安全构成一定威胁.现主要针对AIS患者静脉溶栓后发生HT的危险因素及治疗方案展开综述.
Research progress in risk factors and treatment of hemorrhagic transformation after intravenous thrombolysis in acute ischemic stroke
Intravenous thrombolysis is a commonly used method in the clinical treatment of acute ischemic stroke(AIS),which can restore cerebral blood flow perfusion in time,rescue the dying neurological function,improve the rate of vascular recanalization,and reduce the mortality.However,AIS patients are prone to hemorrhagic transformation(HT)after intravenous thrombolysis.As a more serious complication after intravenous thrombolysis in AIS patients,HT can offset or reduce the benefits of intravenous thrombolysis therapy,and pose certain threat to the life safety of patients.This article mainly reviews the risk factors and treatment plans for HT after intravenous thrombolysis in AIS patients.

acute ischemic strokeintravenous thrombolysishemorrhagic transformationrisk factor

赵奕轩、陈婷、黄欣、周文胜

展开 >

湖南师范大学附属第一医院/湖南省人民医院神经内科,长沙 410002

急性缺血性脑卒中 静脉溶栓 出血转化 危险因素

湖南省卫生健康委科研计划项目

D202303076967

2024

长春中医药大学学报
长春中医药大学

长春中医药大学学报

CSTPCD
影响因子:0.916
ISSN:1007-4813
年,卷(期):2024.40(10)